Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | DGKA | P23743 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6922962 | 0.86 | ATM (0.44) | ATMHCAR2MAPTDGKARAB9A | |
| SCHEMBL181412 | 0.85 | ATM (0.47) | ATMHCAR2MAPTDGKARAB9A | |
| SCHEMBL534938 | 0.82 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL691276 | 0.81 | HCAR2 (0.63) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL691277 | 0.81 | HCAR2 (0.63) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL9561910 | 0.81 | HCAR2 (0.63) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL3390981 | 0.80 | ALDH1A1 (0.52) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL36040 | 0.79 | TSHR (0.50) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL28380009 | 0.78 | CHRM2 (0.48) | ATMHCAR2MAPTALDH1A1 | |
| SCHEMBL27137053 | 0.78 | CHRM5 (0.50) | ATMHCAR2MAPTRAB9AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637804-B2 | Ink jet recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12637578-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12629934-B2 | Recording method and recording device | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12630728-B2 | Ink set and recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12630973-B2 | Recording method | SEIKO EPSON CORPORATION (JP) | 2026-05-19 | — | — | US | disclosed |
| US-12624242-B2 | Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method | SEIKO EPSON CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-20260125850-A1 | Pretreatment Liquid For Textile Printing And Textile Printing Method | SEIKO EPSON CORP (JP) | 2026-05-07 | — | — | US | disclosed |
| US-20260116073-A1 | Maintenance Method And Recording Apparatus | SEIKO EPSON CORP (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12584030-B2 | Ink jet ink composition and recording method | SEIKO EPSON CORPORATION (JP) | 2026-03-24 | — | — | US | disclosed |
| US-12576663-B2 | Treatment method | SEIKO EPSON CORPORATION (JP) | 2026-03-17 | — | — | US | disclosed |
| US-20100126529-A1 | MAINTENANCE LIQUID FOR INKJET PRINTERS | TOYO INK MFG. CO., TLD (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-2157163-A1 | MAINTENANCE LIQUID FOR INKJET PRINTER | Toyo Ink Mfg. Co. Ltd. (JP) | 2010-02-24 | — | — | EP | disclosed |
| US-7604695-B2 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2009-10-20 | — | — | US | disclosed |
| EP-2083054-A1 | NONAQUEOUS INKJET INK AND INK SET | Toyo Ink Mfg. Co. Ltd. (JP) | 2009-07-29 | — | — | EP | disclosed |
| US-7407536-B2 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2008-08-05 | — | — | US | disclosed |
| EP-1790700-B1 | Organic solvent based ink Composition | TOYO INK MFG CO (JP) | 2008-07-02 | — | — | EP | disclosed |
| US-20070119335-A1 | For printing on non-absorbable printing media, containing as a solvent a a hydrofuran-3-one, hydropyranone, oxazolinone, morpholin-3-one or 1,3-hydrooxazin-4-one; odorless, excellent safety and health properties, resin solubility, printing stability and drying properties and causes no corrosion | TOYO INK MFG. CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| US-20070119342-A1 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| EP-1790700-A1 | Organic solvent based ink Composition | TOYO INK MFG. CO., LTD. (JP) | 2007-05-30 | — | — | EP | disclosed |
| EP-1790699-A1 | Ink composition | TOYO INK MFG. CO., LTD. (JP) | 2007-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125850-A1 | Pretreatment Liquid For Textile Printing And Textile Printing Method | ADH1A, RARA, RBP4 | ATM 1577/4885NAAA 3427/4885HCAR2 1203/4885 |
| US-12576663-B2 | Treatment method | EPCAM, FLNA, TAS2R8 | ATM 1181/4885NAAA 3775/4885HCAR2 3746/4885 |
| US-12624242-B2 | Water-based coloring composition, coloring method, pigment dispersion liquid, and metal pigment producing method | HAO2, PHOSPHO1, HAO1 | ATM 3120/4885NAAA 4241/4885HCAR2 2791/4885 |
| US-12637578-B2 | Ink jet ink composition and recording method | TYR, RB1, WNT1 | ATM 1040/4885NAAA 4877/4885HCAR2 4654/4885 |
| US-12630973-B2 | Recording method | DOT1L, EMD, EZH2 | ATM 1555/4885NAAA 948/4885HCAR2 3367/4885 |
| US-20260116073-A1 | Maintenance Method And Recording Apparatus | WFS1, HCN2, SMN1; SMN2 | ATM 2351/4885NAAA 3763/4885HCAR2 4255/4885 |
| US-12629934-B2 | Recording method and recording device | HCN2, MC1R, TYR | ATM 3935/4885NAAA 4749/4885HCAR2 2720/4885 |
| US-12630728-B2 | Ink set and recording method | DOT1L, SET, ALKBH3 | ATM 454/4885NAAA 4728/4885HCAR2 2507/4885 |
| US-12637804-B2 | Ink jet recording method | IK, PRPH, SLC6A19 | ATM 2488/4885NAAA 2548/4885HCAR2 3272/4885 |
| US-12584030-B2 | Ink jet ink composition and recording method | LSM8, SMURF1, SMAD3 | ATM 66/4885NAAA 4255/4885HCAR2 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.